<?xml version="1.0" encoding="UTF-8"?>
<results title="disease">
 <result pre="the PMC Open Access Subset for unrestricted research re-use and" exact="secondary" post="analysis in any form or by any means with"/>
 <result pre="of compounds, nucleoside analogues, thymidine kinase-dependent nucleotide analogues and specific" exact="viral" post="enzyme inhibitors. It has been found that the natural"/>
 <result pre="anti-viral drugs. Keywords Phytochemicals Polysaccharides Flavonoids Organic acids Alkaloids Saponins" exact="Essential" post="oils Stilbenes Antiviral activity assay Introduction A virus is"/>
 <result pre="Stilbenes Antiviral activity assay Introduction A virus is a small," exact="infectious" post="agent, which contains little more than bundles of gene"/>
 <result pre="DNA, and may be surrounded bya shell of protein. Unlike" exact="bacterial" post="cells, which are free-living entities, viruses utilize the host"/>
 <result pre="and proceed to infect other cells within the host. Virus" exact="infection" post="can cause a mild illness as a cold or"/>
 <result pre="as a cold or a deadly illness as the bloody" exact="African" post="fever. The viruses that cause Lassa fever and Ebola"/>
 <result pre="illness as the bloody African fever. The viruses that cause" exact="Lassa fever" post="and Ebola fever and the retrovirus that causes acquired"/>
 <result pre="Lassa fever and Ebola fever and the retrovirus that causes" exact="acquired" post="immunodeficiency syndrome (AIDS) are examples spreading easily, threatening people’s"/>
 <result pre="fever and Ebola fever and the retrovirus that causes acquired" exact="immunodeficiency" post="syndrome (AIDS) are examples spreading easily, threatening people’s life"/>
 <result pre="and Ebola fever and the retrovirus that causes acquired immunodeficiency" exact="syndrome" post="(AIDS) are examples spreading easily, threatening people’s life and"/>
 <result pre="there is no cure or vaccine (Jassim and Naji 2003)." exact="Viral infection" post="has become one of the main causes of morbidity"/>
 <result pre="is no cure or vaccine (Jassim and Naji 2003). Viral" exact="infection" post="has become one of the main causes of morbidity"/>
 <result pre="connected, the designing of effective anti-virals that will inhibit the" exact="viral" post="enzymes or its replication without affecting the host cells"/>
 <result pre="the important means, by which society controls the spread of" exact="viral" post="infections. With the advances in molecular biology and reverse"/>
 <result pre="in their replication cycles, which are their potential targets. Since" exact="viral" post="enzymes are crucial for disease progression and virus replication,"/>
 <result pre="are their potential targets. Since viral enzymes are crucial for" exact="disease" post="progression and virus replication, inhibitors against viral enzymes have"/>
 <result pre="are crucial for disease progression and virus replication, inhibitors against" exact="viral" post="enzymes have been the most desirable strategies. Most of"/>
 <result pre="most desirable strategies. Most of the well-studied inhibitors against HIV," exact="herpes" post="simplex virus (HSV) or the influenza viruses target the"/>
 <result pre="RNA polymerase inhibitors (acyclovir, cidofovir, ribavirin, etc.), proteinase involved in" exact="viral" post="polyprotein precursors and assembly/maturation inhibitors (indinavir, ritonavir and rimantadine,"/>
 <result pre="in the market (Chattopadhyay et al. 2009). The development of" exact="viral" post="resistance towards current antiviral agents enhances the need for"/>
 <result pre="antiviral agents enhances the need for new effective compounds against" exact="viral" post="infections. Some new anti-viral compounds are currently undergoing either"/>
 <result pre="in the past two decades, especially for the treatment of" exact="infectious diseases." post="Approximately 44% of the antiviral drugs approved between 1981"/>
 <result pre="products were directly used for the treatment of diseases, including" exact="viral infection" post="diseases. Natural products have made great contributions to human"/>
 <result pre="were directly used for the treatment of diseases, including viral" exact="infection" post="diseases. Natural products have made great contributions to human"/>
 <result pre="grape, apple, strawberry and other fruit juices against HSV, poliovirus" exact="type 1," post="coxsackievirus B5 and echovirus 7 were reported (Konowalchuk and"/>
 <result pre="out of which showed significant antiviral effect against corona viruses," exact="respiratory" post="syncytial virus (RSV), para-influenza virus type 3 (PI3), herpesvirus"/>
 <result pre="effect against corona viruses, respiratory syncytial virus (RSV), para-influenza virus" exact="type 3" post="(PI3), herpesvirus type 1 (HSV-1) and retavirus (McCutcheon et"/>
 <result pre="respiratory syncytial virus (RSV), para-influenza virus type 3 (PI3), herpesvirus" exact="type 1" post="(HSV-1) and retavirus (McCutcheon et al. 1995). In 1998,"/>
 <result pre="200 Chinese herbal medicines were screened for antiviral activities against" exact="Severe" post="Acute Respiratory Syndrome associated coronavirus (SARS-CoV), 4 out of"/>
 <result pre="Chinese herbal medicines were screened for antiviral activities against Severe" exact="Acute" post="Respiratory Syndrome associated coronavirus (SARS-CoV), 4 out of which"/>
 <result pre="herbal medicines were screened for antiviral activities against Severe Acute" exact="Respiratory" post="Syndrome associated coronavirus (SARS-CoV), 4 out of which showed"/>
 <result pre="medicines were screened for antiviral activities against Severe Acute Respiratory" exact="Syndrome" post="associated coronavirus (SARS-CoV), 4 out of which showed potent"/>
 <result pre="showed potent antiviral activities (Li et al. 2005a). In addition," exact="herpes" post="simplex virus type 2 (HSV-2) (Debiaggi et al. 1988),"/>
 <result pre="activities (Li et al. 2005a). In addition, herpes simplex virus" exact="type 2" post="(HSV-2) (Debiaggi et al. 1988), HIV (Asres and Bucar"/>
 <result pre="1988), HIV (Asres and Bucar 2005; Vermani and Garg 2002)," exact="hepatitis" post="B virus (HBV) (Huang et al. 2003, 2006; Kwon"/>
 <result pre="(Parida et al. 2002; Reis et al. 2008) and emerging" exact="viral" post="infections associated with poxvirus and severe acute respiratory syndrome"/>
 <result pre="et al. 2002; Reis et al. 2008) and emerging viral" exact="infections" post="associated with poxvirus and severe acute respiratory syndrome (SARS)"/>
 <result pre="2008) and emerging viral infections associated with poxvirus and severe" exact="acute" post="respiratory syndrome (SARS) virus (Kotwal et al. 2005) were"/>
 <result pre="and emerging viral infections associated with poxvirus and severe acute" exact="respiratory" post="syndrome (SARS) virus (Kotwal et al. 2005) were strongly"/>
 <result pre="emerging viral infections associated with poxvirus and severe acute respiratory" exact="syndrome" post="(SARS) virus (Kotwal et al. 2005) were strongly inhibited"/>
 <result pre="extracts. Most of these studies utilized either water soluble or" exact="alcoholic" post="extracts of medicinal plants, and limited efforts have been"/>
 <result pre="either water soluble or alcoholic extracts of medicinal plants, and" exact="limited" post="efforts have been directed toward the identification of active"/>
 <result pre="their antiviral activities are shown in Table 3.1. Table 3.1" exact="Partial" post="viruses inhibited by medicinal plants Virus Medicinal plant used"/>
 <result pre="by medicinal plants Virus Medicinal plant used Antiviral effect Reference" exact="Hepatitis" post="C virus (HCV) Acacia nilotica L. Exhibited significant activity"/>
 <result pre="Displayed potential antiviral activity against HCV Javed et al. (2011)" exact="Hepatitis" post="B virus (HBV) Ophioglossum pedunculosum Desv. Exhibit modest activity"/>
 <result pre="secretion in vitro Wan et al. (2011) Boehmeria nivea L." exact="Reduced" post="HBV production in an in vitro and in vivo"/>
 <result pre="Huang et al. (2006) Polygonum cuspidatum Sieb. and Zucc. Inhibited" exact="hepatitis" post="B virus in a stable HBV-producing cell line Chang"/>
 <result pre="cuspidatum Sieb. and Zucc. Inhibited hepatitis B virus in a" exact="stable" post="HBV-producing cell line Chang et al. (2005) Herpes simplex"/>
 <result pre="vitro Serkedjieva and Ivancheva (1999) Influenza virus Geranium sanguineum L." exact="Reduced" post="the infectivity of various influenza virus strains in vitro"/>
 <result pre="Inhibited poliovirus replication, as well as, blocked the synthesis of" exact="viral" post="antigens in infected cell cultures Felipe et al. (2006)"/>
 <result pre="viral antigens in infected cell cultures Felipe et al. (2006)" exact="Viral" post="haemorrhagic septicaemia virus (VHSV) Olea europaea L. Inhibited viral"/>
 <result pre="(2006) Viral haemorrhagic septicaemia virus (VHSV) Olea europaea L. Inhibited" exact="viral" post="replication in vitro Micol et al. (2005) Human immunodeficiency"/>
 <result pre="Inhibited viral replication in vitro Micol et al. (2005) Human" exact="immunodeficiency" post="virus (HIV) Phyllanthus amarus Schum. and Thonn Inhibited HIV"/>
 <result pre="and in vivo Notka et al. (2004) Olive leaf Inhibited" exact="acute" post="infection and cell-to-cell transmission of HIV-1 Lee-Huang et al."/>
 <result pre="in vivo Notka et al. (2004) Olive leaf Inhibited acute" exact="infection" post="and cell-to-cell transmission of HIV-1 Lee-Huang et al. (2003)"/>
 <result pre="and cell-to-cell transmission of HIV-1 Lee-Huang et al. (2003) Vesicular" exact="stomatitis" post="virus (VSV) Trichilia glabra L. Inhibited VSV in vitro"/>
 <result pre="Inhibited VSV in vitro Cella et al. (2004) Human adenovirus" exact="type 1" post="Black soybean Inhibited human adenovirus type 1 and coxsackievirus"/>
 <result pre="(2004) Human adenovirus type 1 Black soybean Inhibited human adenovirus" exact="type 1" post="and coxsackievirus B1 in vitro Yamai et al. (2003)"/>
 <result pre="coxsackievirus B1 in vitro Yamai et al. (2003) Coxsackievirus B1" exact="Dengue" post="virus type-2 (DENV-2) Azadirachta indica Juss.(Neem) Inhibited DENV-2 both"/>
 <result pre="in vitro antiviral activity against DENV-2 Reis et al. (2008)" exact="Severe" post="Acute Respiratory Syndrome associated coronavirus (SARS-CoV) Lycoris radiate, Artemisia"/>
 <result pre="vitro antiviral activity against DENV-2 Reis et al. (2008) Severe" exact="Acute" post="Respiratory Syndrome associated coronavirus (SARS-CoV) Lycoris radiate, Artemisia annua"/>
 <result pre="antiviral activity against DENV-2 Reis et al. (2008) Severe Acute" exact="Respiratory" post="Syndrome associated coronavirus (SARS-CoV) Lycoris radiate, Artemisia annua Showed"/>
 <result pre="activity against DENV-2 Reis et al. (2008) Severe Acute Respiratory" exact="Syndrome" post="associated coronavirus (SARS-CoV) Lycoris radiate, Artemisia annua Showed potent"/>
 <result pre="studies showed that plant extracts possess antiviral potential of against" exact="viral" post="strains resistant to conventional antiviral agents (Serkedjieva 2003; Tolo"/>
 <result pre="used throughout the world, however, their wide usage has been" exact="limited" post="to China, India, Japan, Pakistan, Sri Lanka, Thailand and"/>
 <result pre="India, Japan, Pakistan, Sri Lanka, Thailand and a number of" exact="African" post="countries. However, developed countries are gradually accepting the usage"/>
 <result pre="and cellular level for testing anti-viral agents against common viruses" exact="Virus Disease" post="Molecular level model Cellular level model HSV Herpes DNA"/>
 <result pre="cellular level for testing anti-viral agents against common viruses Virus" exact="Disease" post="Molecular level model Cellular level model HSV Herpes DNA"/>
 <result pre="assays Plaque assay, HA, HAI, RT-PCR (MDCK, A549 cell lines)" exact="Hepatitis" post="C virus (HCV) Liver cirrhosis Protease, RNA polymerase assay"/>
 <result pre="RT-PCR (MDCK, A549 cell lines) Hepatitis C virus (HCV) Liver" exact="cirrhosis" post="Protease, RNA polymerase assay RT- PCR, no cell line"/>
 <result pre="polymerase assay RT- PCR, no cell line facility HBV Liver" exact="cirrhosis" post="Reverse transcriptase assay, interferons RT- PCR (HepG2 2.2.15) Entero"/>
 <result pre="Cell-ELISA, HEp-2 HIV AIDS Reverse transcriptase and integrase activity assays" exact="Primary" post="macrophages, HFF cells Rabies virus Hydrophoba McCoy cells Polio"/>
 <result pre="assays Primary macrophages, HFF cells Rabies virus Hydrophoba McCoy cells" exact="Polio" post="virus Paralysis, Aseptic meningitis RNA polymerase assay Plaque assay,"/>
 <result pre="HFF cells Rabies virus Hydrophoba McCoy cells Polio virus Paralysis," exact="Aseptic meningitis" post="RNA polymerase assay Plaque assay, RT-PCR (Hela cell line)"/>
 <result pre="cells Rabies virus Hydrophoba McCoy cells Polio virus Paralysis, Aseptic" exact="meningitis" post="RNA polymerase assay Plaque assay, RT-PCR (Hela cell line)"/>
 <result pre="compounds or extracts, for their inhibition and action mechanisms on" exact="viral" post="enzymes or function proteins, and therefore provide useful activity"/>
 <result pre="results are expressed in femtograms HIV-1 RT activity/ml plasma. The" exact="lower" post="limit of detection is &amp;lt;1 fg/ml. Results are calculated"/>
 <result pre="RNA equivalent copies/ml using a conversion factor derived from a" exact="Swedish" post="cohort comprised mainly of subtype B virus. Assay precision"/>
 <result pre="M13 (−40) universal primer sequence. Fluorescein-labeled M13 primer (0.5 μM;" exact="Alpha" post="DNA, Montreal, Canada) is annealed to the two templates"/>
 <result pre="(HA) is a quantitation of hemagglutination protein of viruses. Some" exact="viral" post="families have surface or envelope proteins, which are able"/>
 <result pre="assay or LD50, HA does not give any measure of" exact="viral" post="infectivity, because no virus replication is required in this"/>
 <result pre="strengths. If the test compounds inhibit virus replication and thus" exact="viral" post="titre, the HA value will be reduced. HA inhibition"/>
 <result pre="activity of compounds/extracts. It is based on the observation that" exact="virus infection" post="and multiplication results in cytopathic effect (CPE) due to"/>
 <result pre="of compounds/extracts. It is based on the observation that virus" exact="infection" post="and multiplication results in cytopathic effect (CPE) due to"/>
 <result pre="measured with the CPE inhibition assay (Liu et al. 2008b)." exact="Viral" post="suspension (200 TCID50/ml, 100 μl) is added to each"/>
 <result pre="each well, using the MNCC as the highest concentration. An" exact="infection" post="control without samples is also included. The plates are"/>
 <result pre="1% (w/v) crystal violet solution. The plaques are counted by" exact="visual" post="examination and percentage of plaque inhibition is calculated as"/>
 <result pre="for 5 min). Cell pellets are washed with PBS twice." exact="Total" post="cellular and viral RNAs are isolated from pellets using"/>
 <result pre="Cell pellets are washed with PBS twice. Total cellular and" exact="viral" post="RNAs are isolated from pellets using the RNeasy mini"/>
 <result pre="manufacture’s protocol. First-strand cDNA is synthesized from 1 μg of" exact="total" post="RNA with Omniscript RT kit (QIAGEN) using specific primers."/>
 <result pre="detection and the primer sequences used for the detection of" exact="viral" post="RNA are 5′-TGC TGG ATT CTC GTT CGG TC"/>
 <result pre="Linked Immunosorbent Assay (ELISA) ELISA assays allow the detection of" exact="viral" post="antigen or antibody, using a solid-phase assay system. Although"/>
 <result pre="virus. Absolute quanitation is possible if a series of pre-determined" exact="viral" post="titres are used to get elisa readings and matched"/>
 <result pre="virus samples (untreated or drug-treated). The method cannot differentiate between" exact="infectious" post="and non-infectious virus particles as a result of which"/>
 <result pre="the drug affecting at the earlier or latter stage of" exact="viral" post="replication or maturation may not be understood (Chattopadhyay et"/>
 <result pre="is taken photometrically at OD450. Alternatively, the drug treatment and" exact="virus infection" post="can be performed in 96-well formats, instead of preparing"/>
 <result pre="taken photometrically at OD450. Alternatively, the drug treatment and virus" exact="infection" post="can be performed in 96-well formats, instead of preparing"/>
 <result pre="overlaid with log10 dilution of test compounds followed by the" exact="infection" post="with virus. After 16–20 h incubation at 37°C, monolayers"/>
 <result pre="involves additional difficulties, particularly due to the nature of the" exact="infectious" post="viruses. Thus, many compounds that may cause the death"/>
 <result pre="medicinal plants are of interest as possible source to control" exact="viral infection," post="which include flavonoids, alkaloids, polysaccharides, organic acids, essential oils,"/>
 <result pre="DENV-3 Gymnogongrus griffithsiae and Cryptonemia crenulata Talarico et al. (2005)" exact="Protein" post="bound polysaccharides Exhibited potent HSV-1 and HSV-2 antiviral activity"/>
 <result pre="et al. 1995), human cytomegalovirus (HCMV) (Baba et al. 1988)," exact="respiratory" post="syncytial virus, influenza A and B virus (Damonte et"/>
 <result pre="the positively charged sites in the V3 loop of the" exact="viral" post="envelope glycoprotein (gp120), which is necessary for virus attachment"/>
 <result pre="necessary for virus attachment to cell surface heparan sulfate, a" exact="primary" post="binding site, before more specific binding occurs to the"/>
 <result pre="antiviral activity of polysulfates against enveloped viruses. Variations in the" exact="viral" post="envelope glycoprotein region may result in differences in the"/>
 <result pre="with their envelope glycoproteins. The efficacy of sulfated polysaccharide against" exact="herpes" post="simplex virus types 1 and 2 (HSV-1 and -2)"/>
 <result pre="glycoproteins. The efficacy of sulfated polysaccharide against herpes simplex virus" exact="types 1 and 2" post="(HSV-1 and -2) were demonstrated in vivo (rats and"/>
 <result pre="and DEAE-cellulose column chromatography, displayed antiviral activities against HSV-1 and" exact="type 2" post="(HSV-2). The study on its action mechanism suggested that"/>
 <result pre="The study on its action mechanism suggested that GLPG inhibits" exact="viral" post="replication by interfering with the early events of viral"/>
 <result pre="inhibits viral replication by interfering with the early events of" exact="viral" post="adsorption and entry into target cells (Liu et al."/>
 <result pre="extract had less weight loss than untreated mice but similar" exact="pulmonary" post="viral titers. Echinacea-treated mice had lower systemic and pulmonary"/>
 <result pre="had less weight loss than untreated mice but similar pulmonary" exact="viral" post="titers. Echinacea-treated mice had lower systemic and pulmonary KC"/>
 <result pre="untreated mice but similar pulmonary viral titers. Echinacea-treated mice had" exact="lower" post="systemic and pulmonary KC and IL-10 levels and lower"/>
 <result pre="mice but similar pulmonary viral titers. Echinacea-treated mice had lower" exact="systemic" post="and pulmonary KC and IL-10 levels and lower systemic"/>
 <result pre="similar pulmonary viral titers. Echinacea-treated mice had lower systemic and" exact="pulmonary" post="KC and IL-10 levels and lower systemic IFN-γ levels"/>
 <result pre="had lower systemic and pulmonary KC and IL-10 levels and" exact="lower" post="systemic IFN-γ levels following influenza infection. These suggest that"/>
 <result pre="lower systemic and pulmonary KC and IL-10 levels and lower" exact="systemic" post="IFN-γ levels following influenza infection. These suggest that E."/>
 <result pre="suggest that E. purpurea alters the clinical course of influenza" exact="infection" post="in mice through modulation of cytokines and not direct"/>
 <result pre="humans and animals, including adenovirus, HSV, HIV, porcine reproductive and" exact="respiratory" post="syndrome virus, and rotavirus (Andres et al. 2009). Current"/>
 <result pre="and animals, including adenovirus, HSV, HIV, porcine reproductive and respiratory" exact="syndrome" post="virus, and rotavirus (Andres et al. 2009). Current results"/>
 <result pre="Flavonoids have been reported to affect virus binding, entry, replication," exact="viral" post="protein translation, formation of certain virus envelope glycoprotein complexes"/>
 <result pre="et al. (2008) BHV-1 MDBK cells Akula et al. (2002)" exact="Bovine" post="viral diarrhea virus MDBK cells Lecot et al. (2005)"/>
 <result pre="al. (2008) BHV-1 MDBK cells Akula et al. (2002) Bovine" exact="viral" post="diarrhea virus MDBK cells Lecot et al. (2005) EBV"/>
 <result pre="(2008) BHV-1 MDBK cells Akula et al. (2002) Bovine viral" exact="diarrhea" post="virus MDBK cells Lecot et al. (2005) EBV Ramos"/>
 <result pre="al. (2005) HHV-8 HFF cells Sharma-Walia et al. (2004) HIV" exact="Primary" post="macrophages Stantchev et al. (2007) MoMLV XC cells Kubo"/>
 <result pre="and MRC-5 cells Hayashi et al. (1997) Irisolidone JC virus" exact="Primary" post="astrocytes Kim et al. (2006) 3-Methylkaempferol Poliovirus Vero cells"/>
 <result pre="revealed that, at high concentration, EGCG and ECG also suppressed" exact="viral" post="RNA synthesis in MDCK cells whereas EGC failed to"/>
 <result pre="has not only potential use as adjunctive therapy in HIV-1" exact="infection" post="(Williamson et al. 2006), but has greater anti-HSV activity"/>
 <result pre="suggesting that EGCG inhibits one or more late steps in" exact="virus infection" post="(Webster et al. 2006). It is worth to mention"/>
 <result pre="that EGCG inhibits one or more late steps in virus" exact="infection" post="(Webster et al. 2006). It is worth to mention"/>
 <result pre="The flavonoids apigenin and luteolin displayed significant in vitro anti-influenza" exact="viral" post="activity, which were isolated from the traditional Chinese medicinal"/>
 <result pre="block human cytomegalovirus (HCMV) replication at concentrations that were significantly" exact="lower" post="than those producing cytotoxicity against growing or stationary phase"/>
 <result pre="The study of their mechanisms of action suggested that the" exact="primary" post="mechanism of action for baicalein may be to block"/>
 <result pre="mechanism of action for baicalein may be to block HCMV" exact="infection" post="at entry while the primary mechanism of action for"/>
 <result pre="may be to block HCMV infection at entry while the" exact="primary" post="mechanism of action for genistein may be to block"/>
 <result pre="addition, Q3R inhibited virus replication in the initial stage of" exact="virus infection" post="by indirect interaction with virus particles. Therefore, these findings"/>
 <result pre="Q3R inhibited virus replication in the initial stage of virus" exact="infection" post="by indirect interaction with virus particles. Therefore, these findings"/>
 <result pre="treatment of lesions in the mouth and often related to" exact="acute" post="herpetic gingivo-stomatitis, displayed antiviral activity against HSV-1 DNA viral"/>
 <result pre="to acute herpetic gingivo-stomatitis, displayed antiviral activity against HSV-1 DNA" exact="viral" post="strains KOS and VR733 (ATCC) (Fritz et al. 2007)."/>
 <result pre="and for their exploitation and utilization for the treatment of" exact="viral infection." post="Organic Acids Besides, some natural organic acids also possess"/>
 <result pre="host cells, and could not protect HEp-2 cells from RSV" exact="infection" post="at lower concentrations. The data suggest that the compounds"/>
 <result pre="and could not protect HEp-2 cells from RSV infection at" exact="lower" post="concentrations. The data suggest that the compounds exert their"/>
 <result pre="was studied in vitro against several viruses including HSV-1, adenovirus" exact="type 6," post="vaccinia, vesicular stomatitis and poliovirus (Amoros et al. 1987)."/>
 <result pre="against several viruses including HSV-1, adenovirus type 6, vaccinia, vesicular" exact="stomatitis" post="and poliovirus (Amoros et al. 1987). The drug was"/>
 <result pre="was found to inhibit the replication of HSV-1 and poliovirus" exact="type 2" post="as shown by inhibition of cytopathic effect and reduction"/>
 <result pre="that saponins interfered with both early and late events of" exact="herpes" post="virus replication (Amoros et al. 1987). The Tibetan herb"/>
 <result pre="on Peking ducklings also demonstrated that this compound inhibits duck" exact="hepatitis" post="B virus (DHBV) DNA replication (Zhao et al. 2008)."/>
 <result pre="structure of the most active saponin from Potentilla anserina L." exact="Essential" post="Oils The application of essential oils as possible therapeutic"/>
 <result pre="natural and traditional medicines that are also effective on resistant" exact="bacterial" post="or viral strains have stimulated investigations into the bioactive"/>
 <result pre="traditional medicines that are also effective on resistant bacterial or" exact="viral" post="strains have stimulated investigations into the bioactive properties of"/>
 <result pre="essential oil showed significant antiviral activity against Herpes simplex virus" exact="type 1" post="(HSV-1) (Sinico et al. 2005). Peppermint oil, the essential"/>
 <result pre="essential oils might be suitable for topical treatment of herpetic" exact="infections" post="(Schnitzler et al. 2008). The wood essential oil from"/>
 <result pre="used as traditional medicine in Lebanon for treatment of different" exact="infection" post="diseases are mainly consist of himachalol (22.50%), β-himachalene (21.90%),"/>
 <result pre="against HSV-2 mainly before adsorption probably by interacting with the" exact="viral" post="envelope (Koch et al. 2008). Camomile oil exhibited a"/>
 <result pre="for topical therapeutic application as virucidal agents for treatment of" exact="herpes" post="genitalis (Koch et al. 2008). Stilbenes In recent years,"/>
 <result pre="lianas of Gnetum pendulum (Gnetaceae), exhibited significant in vitro anti-influenza" exact="viral" post="activities in MDCK cells with IC50 values from 0.67"/>
 <result pre="oriental countries, exhibited antiviral activity against HSV-2 but not HSV-1" exact="infection" post="(Fig. 3.7; Yang et al. 2007). Fig. 3.7 The"/>
 <result pre="al. 2001). The compound inhibited an early stage in the" exact="viral" post="replication cycle, but did not have an irreversible virucidal"/>
 <result pre="which were tested: Coxsackievirus types A21 and B4, human rhinovirus" exact="type 2" post="(Picornaviridae), and the enveloped viruses Ross River virus (Togaviridae)"/>
 <result pre="(3-methyl-1,6,8-trihydroxyanthraquinone) and aloe-emodin were also tested for activity against poliovirus" exact="type 3" post="(Semple et al. 2001). None of the four compounds"/>
 <result pre="roots of Rheum tanguticum possess remarkable antiviral activity against HSV" exact="infection" post="in vitro and in vivo (Xiong et al. 2011),"/>
 <result pre="the new drug discovery and development for the treatment of" exact="viral infection" post="disease. Future Perspective Not only the common viral diseases"/>
 <result pre="new drug discovery and development for the treatment of viral" exact="infection" post="disease. Future Perspective Not only the common viral diseases"/>
 <result pre="of viral infection disease. Future Perspective Not only the common" exact="viral" post="diseases are still fatal, but new viral infections have"/>
 <result pre="only the common viral diseases are still fatal, but new" exact="viral" post="infections have emerged in worldwide in recent years. The"/>
 <result pre="the common viral diseases are still fatal, but new viral" exact="infections" post="have emerged in worldwide in recent years. The currently"/>
 <result pre="example with HIV and hepatitis. Because of the tendency of" exact="viral" post="mutation to drug-resistant forms, it is essential to continue"/>
 <result pre="of some of the medicinal plants for the treatment of" exact="infectious diseases" post="of viral origin, therefore, is justified. In conclusion, active"/>
 <result pre="the medicinal plants for the treatment of infectious diseases of" exact="viral" post="origin, therefore, is justified. In conclusion, active phytochemicals will"/>
 <result pre="antiviral activity of a saponin from Anagallis arvensis, Primulaceae, against" exact="herpes" post="simplex virus and poliovirusAntiviral Res1987813252825589 AmorosMSimoesCMGirreLet al.Synergistic effect of"/>
 <result pre="poliovirusAntiviral Res1987813252825589 AmorosMSimoesCMGirreLet al.Synergistic effect of flavones and flavonols against" exact="herpes" post="simplex virus type 1 in cell culture. Comparison with"/>
 <result pre="al.Synergistic effect of flavones and flavonols against herpes simplex virus" exact="type 1" post="in cell culture. Comparison with the antiviral activity of"/>
 <result pre="al.Isoflavones at concentrations present in soy infant formula inhibit rotavirus" exact="infection" post="in vitroJ Nutr20071372068207317709444 AndresADonovanSMKuhlenschmidtMSSoy isoflavones and virus infectionsJ Nutr"/>
 <result pre="glycosides from the fruits of Solanum torvumPhytochemistry20025945946311830167 AsresKBucarFAnti-HIV activity against" exact="immunodeficiency" post="virus type 1 (HIV-I) and type II (HIV-II) of"/>
 <result pre="the fruits of Solanum torvumPhytochemistry20025945946311830167 AsresKBucarFAnti-HIV activity against immunodeficiency virus" exact="type 1" post="(HIV-I) and type II (HIV-II) of compounds isolated from"/>
 <result pre="torvumPhytochemistry20025945946311830167 AsresKBucarFAnti-HIV activity against immunodeficiency virus type 1 (HIV-I) and" exact="type II" post="(HIV-II) of compounds isolated from the stem bark of"/>
 <result pre="of Combretum molleEthiop Med J200543152016370525 AsresKBucarFKartnigTet al.Antiviral activity against human" exact="immunodeficiency" post="virus type 1 (HIV-1) and type 2 (HIV-2) of"/>
 <result pre="molleEthiop Med J200543152016370525 AsresKBucarFKartnigTet al.Antiviral activity against human immunodeficiency virus" exact="type 1" post="(HIV-1) and type 2 (HIV-2) of ethnobotanically selected Ethiopian"/>
 <result pre="al.Antiviral activity against human immunodeficiency virus type 1 (HIV-1) and" exact="type 2" post="(HIV-2) of ethnobotanically selected Ethiopian medicinal plantsPhytother Res200115626911180526 BabaMNakajimaMScholsDet"/>
 <result pre="leavesRev Argent Microbiol20043613613815559196 ChangJSLiuHWWangKCet al.Ethanol extract of Polygonum cuspidatum inhibits" exact="hepatitis" post="B virus in a stable HBV-producing cell lineAntiviral Res200566293415781129"/>
 <result pre="extract of Polygonum cuspidatum inhibits hepatitis B virus in a" exact="stable" post="HBV-producing cell lineAntiviral Res200566293415781129 ChantrillBHCoulthardCEDickinsonLet al.The action of plant"/>
 <result pre="virus 40 induces an ERK/MAP kinase-independent signalling pathway that activates" exact="primary" post="response genes and promotes virus entryJ Gen Virol199677217321828811017 De"/>
 <result pre="Res20004817718511164504 DebiaggiMPaganiLCeredaPMet al.Antiviral activity of Chamaecyparis lawsoniana extract: study with" exact="herpes" post="simplex virus type 2Microbiologica19881155612832710 DemeuleMMichaud-LevesqueJAnnabiBet al.Green tea catechins as"/>
 <result pre="Chem Anticancer Agents2002244146312678730 DochertyJJSmithJSFuMMet al.Effect of topically applied resveratrol on" exact="cutaneous" post="herpes simplex virus infections in hairless miceAntiviral Res200461192614670590 DochertyJJFuMMHahJMet"/>
 <result pre="Anticancer Agents2002244146312678730 DochertyJJSmithJSFuMMet al.Effect of topically applied resveratrol on cutaneous" exact="herpes" post="simplex virus infections in hairless miceAntiviral Res200461192614670590 DochertyJJFuMMHahJMet al.Effect"/>
 <result pre="al.Effect of topically applied resveratrol on cutaneous herpes simplex virus" exact="infections" post="in hairless miceAntiviral Res200461192614670590 DochertyJJFuMMHahJMet al.Effect of resveratrol on"/>
 <result pre="infections in hairless miceAntiviral Res200461192614670590 DochertyJJFuMMHahJMet al.Effect of resveratrol on" exact="herpes" post="simplex virus vaginal infection in the mouseAntiviral Res20056715516216125258 DochertyJJSweetTJBaileyEet"/>
 <result pre="Res200461192614670590 DochertyJJFuMMHahJMet al.Effect of resveratrol on herpes simplex virus vaginal" exact="infection" post="in the mouseAntiviral Res20056715516216125258 DochertyJJSweetTJBaileyEet al.Resveratrol inhibition of varicella-zoster"/>
 <result pre="of sulfated galactans from the marine alga Bostrychia montagnei on" exact="herpes" post="simplex virus replication in vitroPhytomedicine20018535811292240 EoSKKimYSLeeCKet al.Possible mode of"/>
 <result pre="of acidic protein bound polysaccharide isolated from Ganoderma lucidum on" exact="herpes" post="simplex virusesJ Ethnopharmacol20007247548110996289 EversDLChaoCFWangXet al.Human cytomegalovirus-inhibitory flavonoids: studies on"/>
 <result pre="Virol2005798655866015956608 FuscoDLiuXSavageCet al.Echinacea purpurea aerial extract alters course of influenza" exact="infection" post="in miceVaccine2010283956396220382242 GarciaGCavallaroLBroussalisAet al.Biological and chemical characterization of the"/>
 <result pre="GreinerLLStahlyTSStabelTJThe effect of dietary soy genistein on pig growth and" exact="viral" post="replication during a viral challengeJ Anim Sci2001791272127911374547 HayashiKHayashiTOtsukaHet al.Antiviral"/>
 <result pre="soy genistein on pig growth and viral replication during a" exact="viral" post="challengeJ Anim Sci2001791272127911374547 HayashiKHayashiTOtsukaHet al.Antiviral activity of 5,6,7- trimethoxyflavone"/>
 <result pre="al.Identification of structural features of heparin required for inhibition of" exact="herpes" post="simplex virus type 1 bindingVirology1995206110811167856085 HuangRLHuangYLOuJCet al.Screening of 25"/>
 <result pre="features of heparin required for inhibition of herpes simplex virus" exact="type 1" post="bindingVirology1995206110811167856085 HuangRLHuangYLOuJCet al.Screening of 25 compounds isolated from Phyllanthus"/>
 <result pre="al.Screening of 25 compounds isolated from Phyllanthus species for anti-human" exact="hepatitis" post="B virus in vitroPhytother Res20031744945312748977 HuangKLLaiYKLinCCInhibition of hepatitis B"/>
 <result pre="for anti-human hepatitis B virus in vitroPhytother Res20031744945312748977 HuangKLLaiYKLinCCInhibition of" exact="hepatitis" post="B virus production by Boehmeria nivea root extract in"/>
 <result pre="cellsWorld J Gastroenterol2006125721572517007029 HuheihelMIshanuVTalJet al.Activity of Porphyridium sp polysaccharide against" exact="herpes" post="simplex viruses in vitro and in vivoJ Biochem Biophys"/>
 <result pre="Biochem Biophys Methods20025018920011741707 IsaacsCEWenGYXuWet al.Epigallocatechin gallate inactivates clinical isolates of" exact="herpes" post="simplex virusAntimicrob Agents Chemother20085296297018195068 JassimSANajiMANovel antiviral agents: a medicinal"/>
 <result pre="Appl Microbiol20039541242712911688 JavedTAshfaqUARiazSet al.In-vitro antiviral activity of Solanum nigrum against" exact="Hepatitis" post="C VirusVirol J201182621247464 Jiang ZR (2005) Chinese economic pillars"/>
 <result pre="Biophys Res Commun20063443816630573 KochCReichlingJSchneeleJet al.Inhibitory effect of essential oils against" exact="herpes" post="simplex virus type 2Phytomedicine200815717817976968 KonowalchukJSpeirsJIVirus inactivation by grapes and"/>
 <result pre="protein tyrosine kinase inhibitor, suppresses the fusogenicity of Moloney murine" exact="leukemia" post="virus envelope protein in XC cellsArch Virol20031481899191414551814 KwonDHKwonHYKimHJet al.Inhibition"/>
 <result pre="virus envelope protein in XC cellsArch Virol20031481899191414551814 KwonDHKwonHYKimHJet al.Inhibition of" exact="hepatitis" post="B virus by an aqueous extract of Agrimonia eupatoria"/>
 <result pre="an aqueous extract of Agrimonia eupatoria LPhytother Res20051935535816041735 LecotSBelouzardSDubuissonJet al.Bovine" exact="viral" post="diarrhea virus entry is dependent on clathrin-mediated endocytosisJ Virol200579108261082916051874"/>
 <result pre="aqueous extract of Agrimonia eupatoria LPhytother Res20051935535816041735 LecotSBelouzardSDubuissonJet al.Bovine viral" exact="diarrhea" post="virus entry is dependent on clathrin-mediated endocytosisJ Virol200579108261082916051874 Lee-HuangSZhangLHuangPLet"/>
 <result pre="(OLE) and modulation of host cell gene expression by HIV-1" exact="infection" post="and OLE treatmentBiochem Biophys Res Commun20033071029103712878215 LestiennePPourquierPBonnetJElongation of oligonucleotide"/>
 <result pre="era or an endless frontier?Science200932516116519589993 LiBQFuTDongyanYMikovitsJAet al.Flavonoid baicalin inhibits HIV-1" exact="infection" post="at the level of viral entryBiochem Biophys Res Commun200027653453811027509"/>
 <result pre="LiBQFuTDongyanYMikovitsJAet al.Flavonoid baicalin inhibits HIV-1 infection at the level of" exact="viral" post="entryBiochem Biophys Res Commun200027653453811027509 LiEStupackDGBrownSLet al.Association of p130CAS with"/>
 <result pre="in vitro anti-viral activitiesBioorg Med Chem2008167141714718640042 LiuALShuSHQinHLet al.In vitro anti-influenza" exact="viral" post="activities of constituents from Caesalpinia sappanPlanta Med20097533733919148862 Liu AL,"/>
 <result pre="Yang F, Zu M et al (2010) In vitro anti-influenza" exact="viral" post="activities of stilbenoids from the lianas of Gnetum pendulum."/>
 <result pre="analysis and in vitro evaluation of the biological activity against" exact="herpes" post="simplex virus type 1 (HSV-1) of Cedrus libani A."/>
 <result pre="vitro evaluation of the biological activity against herpes simplex virus" exact="type 1" post="(HSV-1) of Cedrus libani A. RichPhytomedicine200815798317482448 LopesDORegis-da-SilvaCGMachado-SilvaAet al.Analysis of"/>
 <result pre="herbal medicines1998KunmingYunnan Science and Technology LyuSYRhimJYParkWBAntiherpetic activities of flavonoids against" exact="herpes" post="simplex virus type 1 (HSV-1) and type 2 (HSV-2)"/>
 <result pre="and Technology LyuSYRhimJYParkWBAntiherpetic activities of flavonoids against herpes simplex virus" exact="type 1" post="(HSV-1) and type 2 (HSV-2) in vitroArch Pharm Res2005281293130116350858"/>
 <result pre="of flavonoids against herpes simplex virus type 1 (HSV-1) and" exact="type 2" post="(HSV-2) in vitroArch Pharm Res2005281293130116350858 MarchettiMPisaniSPietropaoloVet al.Antiviral effect of"/>
 <result pre="MarchettiMPisaniSPietropaoloVet al.Antiviral effect of a polysaccharide from Sclerotium glucanicum towards" exact="herpes" post="simplex virus type 1 infectionPlanta Med1996623033078792659 MartinezMJOlmoLMBenitoPBAntiviral activities of"/>
 <result pre="of a polysaccharide from Sclerotium glucanicum towards herpes simplex virus" exact="type 1" post="infectionPlanta Med1996623033078792659 MartinezMJOlmoLMBenitoPBAntiviral activities of polysaccharides from natural sourcesStud"/>
 <result pre="Ethnopharmacol1995491011108847882 MicolVCaturlaNPérez-FonsLet al.The olive leaf extract exhibits antiviral activity against" exact="viral" post="haemorrhagic septicaemia rhabdovirus (VHSV)Antiviral Res20056612913615869811 MikiKNagaiTSuzukiKet al.Anti-influenza virus activity"/>
 <result pre="recruitment in SV40-induced internalization of caveolaeScience200229653553911964480 PremanathanMKathiresanKYamamotoNet al.In vitro anti-human" exact="immunodeficiency" post="virus activity of polysaccharide from Rhizophora mucronata PoirBiosci Biotechnol"/>
 <result pre="spirulan-like substancesAntiviral Res20067219720616884788 RehmanSAshfaqUARiazSet al.Antiviral activity of Acacia nilotica against" exact="Hepatitis" post="C Virus in liver infected cellsVirol J2011822021569385 ReisSRValenteLMSampaioALet al.Immunomodulating"/>
 <result pre="antiviral activities of Uncaria tomentosa on human monocytes infected with" exact="Dengue" post="Virus-2Int Immunopharmacol2008846847618279801 Reuter J, Wölfle U, Weckesser S (2010)"/>
 <result pre="J, Wölfle U, Weckesser S (2010) Which plant for which" exact="skin disease?" post="Part 1: atopic dermatitis, psoriasis, acne, condyloma and herpes"/>
 <result pre="S (2010) Which plant for which skin disease? Part 1:" exact="atopic dermatitis," post="psoriasis, acne, condyloma and herpes simplex. J Dtsch Dermatol"/>
 <result pre="skin disease? Part 1: atopic dermatitis, psoriasis, acne, condyloma and" exact="herpes" post="simplex. J Dtsch Dermatol Ges. doi:10.1111/j.1610-0387.2010.07496.x RixonHWBrownGMurrayJTet al.The respiratory"/>
 <result pre="and herpes simplex. J Dtsch Dermatol Ges. doi:10.1111/j.1610-0387.2010.07496.x RixonHWBrownGMurrayJTet al.The" exact="respiratory" post="syncytial virus small hydrophobic protein is phosphorylated via a"/>
 <result pre="the molecular level of the antiviral drug 3(2H)- isoflavene against" exact="type 2" post="poliovirusAntimicrob Agents Chemother2004482233224315155227 SchnitzlerPSchuhmacherAAstaniAet al.Melissa officinalis oil affects infectivity"/>
 <result pre="herpesvirusesPhytomedicine20081573474018693101 SchuhmacherAReichlingJSchnitzlerPVirucidal effect of peppermint oil on the enveloped viruses" exact="herpes" post="simplex virus type 1 and type 2 in vitroPhytomedicine20031050451013678235"/>
 <result pre="of peppermint oil on the enveloped viruses herpes simplex virus" exact="type 1" post="and type 2 in vitroPhytomedicine20031050451013678235 SempleSJNobbsSFPykeSMet al.Antiviral flavonoid from"/>
 <result pre="on the enveloped viruses herpes simplex virus type 1 and" exact="type 2" post="in vitroPhytomedicine20031050451013678235 SempleSJNobbsSFPykeSMet al.Antiviral flavonoid from Pterocaulon sphacelatum, an"/>
 <result pre="preparation from Geranium sanguineum LPharmazie1997527998029362094 SerkedjievaJInfluenza virus variants with reduced" exact="susceptibility to" post="inhibition by a polyphenol extract from Geranium sanguineum LPharmazie200358535712622254"/>
 <result pre="sarcoma-associated herpesvirus/human herpesvirus 8 envelope glycoprotein gB induces the integrin-dependent" exact="focal" post="adhesion kinase-Src-phosphatidylinositol 3-kinase-rho GTPase signal pathways and cytoskeletal rearrangementsJ"/>
 <result pre="issues in traditional Chinese medicineCan J Physiol Pharmacol20058332133415877107 SivapalasingamSEssajeeSNyambiPNet al.Human" exact="immunodeficiency" post="virus (HIV) reverse transcriptase activity correlates with HIV RNA"/>
 <result pre="virusAntiviral Res200568667416137775 StantchevTSMarkovicITelfordWGet al.The tyrosine kinase inhibitor genistein blocks HIV-1" exact="infection" post="in primary human macrophagesVirus Res200712317818917030448 TalaricoLBPujolCAZibettiRGet al.The antiviral activity"/>
 <result pre="StantchevTSMarkovicITelfordWGet al.The tyrosine kinase inhibitor genistein blocks HIV-1 infection in" exact="primary" post="human macrophagesVirus Res200712317818917030448 TalaricoLBPujolCAZibettiRGet al.The antiviral activity of sulfated"/>
 <result pre="the extracts of a Kenyan medicinal plant Carissa edulis against" exact="herpes" post="simplex virusJ Ethnopharmacol2006104929916198524 TuskeSSinghKKaushikNet al.The J-helix of Escherichia coli"/>
 <result pre="vitroAntiviral Res20098318619019463857 WangJHuYWangDet al.Lycium barbarum polysaccharide inhibits the infectivity of" exact="Newcastle disease" post="virus to chicken embryo fibroblastInt J Biol Macromol20104621221619962398 WebsterDTaschereauPLeeTDImmunostimulant"/>
 <result pre="Res20098318619019463857 WangJHuYWangDet al.Lycium barbarum polysaccharide inhibits the infectivity of Newcastle" exact="disease" post="virus to chicken embryo fibroblastInt J Biol Macromol20104621221619962398 WebsterDTaschereauPLeeTDImmunostimulant"/>
 <result pre="anthraquinone derivative extracted from the roots of Rheum tanguticum, against" exact="herpes" post="simplex virus in vitro and in vivoJ Ethnopharmacol201113371872321050882 XuHXLeeSHLeeSFet"/>
 <result pre="a hot water extract of black soybean against a human" exact="respiratory" post="illness virusBiosci Biotechnol Biochem2003671071107912834285 YangCMChengHYLinTCHippomanin A from acetone extract"/>
 <result pre="acetone extract of Phyllanthus urinaria inhibited HSV-2 but not HSV-1" exact="infection" post="in vitroPhytother Res2007211182118617661333 YiLLiZYuanKQuXet al.Small molecules blocking the entry"/>
 <result pre="vitroPhytother Res2007211182118617661333 YiLLiZYuanKQuXet al.Small molecules blocking the entry of severe" exact="acute" post="respiratory syndrome coronavirus into host cellsJ Virol200478113341133915452254 YuraYYoshidaHSatoMInhibition of"/>
 <result pre="Res2007211182118617661333 YiLLiZYuanKQuXet al.Small molecules blocking the entry of severe acute" exact="respiratory" post="syndrome coronavirus into host cellsJ Virol200478113341133915452254 YuraYYoshidaHSatoMInhibition of herpes"/>
 <result pre="YiLLiZYuanKQuXet al.Small molecules blocking the entry of severe acute respiratory" exact="syndrome" post="coronavirus into host cellsJ Virol200478113341133915452254 YuraYYoshidaHSatoMInhibition of herpes simplex"/>
 <result pre="acute respiratory syndrome coronavirus into host cellsJ Virol200478113341133915452254 YuraYYoshidaHSatoMInhibition of" exact="herpes" post="simplex virus replication by genistein, an inhibitor of protein-tyrosine"/>
</results>
